The Smokerlyzer® has been utilized in thousands of studies over the last 30+ years as a tool to chemically validate abstinence. It has been the main FDA cleared biochemical validation measure in clinical trials used to bring smoking cessation pharmacotherapies, like the nicotine patch and other NRT products, to market and is used by every major research institution in the United States. The Smokerlyzer® has set the industry standard with a reliability matched by none.
Helping people to stop smoking, one breath at a time.
Tobacco Treatment Specialists have relied on our Smokerlyzers® for over 30 years as a means to provide motivation to smokers to help them on their journey to stop smoking. Smokerlyzers® offer the smoker personalized biofeedback about their unique smoking habit, and years of research, as well as the clinical experience of those in the field treating smokers, has demonstrated the effectiveness of this powerful device in the smoking cessation toolkit.
Respiratory therapists were historically the medical professionals who tended to engage smokers most directly due to respiratory illnesses associated with smoking. They were some of the original end-users of our Smokerlyzers® and continue to be one of our largest segments of end-users. Like tobacco treatment professionals, the Smokerlyzer® is an essential tool in helping to provide motivation to smokers to help them stop smoking.
There is plenty of evidence in the medical literature that smoking before and after surgery interferes with the healing process and can lead to complications (ACS 2014). This is why anesthesiologists and surgeons at some of the leading hospitals in the U.S. have adopted the Smokerlyzer® to screen smokers pre and post surgery, and use it refer them to counseling for tobacco treatment.
Primary Care Physicians
Primary care physicians and their staff are uniquely positioned to counsel smokers in a meaningful way, and patients rely on their advice. Smokers under their care can be offered a Smokerlyzer® test during office visits as a powerful demonstration of biofeedback. Physicians can then refer patients to tobacco treatment counseling or to the appropriate medications to assist in the stop smoking process(Ask, Advice, Refer). With an average reimbursement of $29.03 per test, breath CO testing using our Smokerlyzer® monitor can become a great revenue source for your practice while also helping your patients.